XTX Topco’s Ascendis Pharma A/S ASND Stock Holding History

XTX Topco’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.5M	Buy	43,289 +31,217	+259%	+$7.29M	0.15%	90
2026 Q1	$2.76M	Buy	12,072 +7,613	+171%	+$1.71M	0.05%	607
2025 Q4	$951K	Buy	+4,459	New	+$921K	0.03%	1061
2025 Q3	–	Sell	-6,066	Closed	-$1.05M	–	2538
2025 Q2	$1.05M	Buy	6,066 +2,320	+62%	+$378K	0.04%	639
2025 Q1	$584K	Buy	+3,746	New	+$535K	0.03%	914
2024 Q4	–	Sell	-11,333	Closed	-$1.69M	–	2276
2024 Q3	$1.69M	Buy	+11,333	New	+$1.53M	0.12%	196
2023 Q4	–	Sell	-2,398	Closed	-$225K	–	1575
2023 Q3	$225K	Sell	2,398 -243	-9%	-$22.7K	0.04%	953
2023 Q2	$236K	Buy	+2,641	New	+$230K	0.04%	895
2021 Q4	–	Sell	-3,250	Closed	-$518K	–	676
2021 Q3	$518K	Buy	+3,250	New	+$445K	0.17%	179

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

XTX Topco's ASND Position: Q2 2026 in Review

XTX Topco increased its Ascendis Pharma A/S (ASND) stake by 259% in Q2 2026, buying an estimated $7.29M and bringing the position to 43,289 shares worth $11.5M. The position accounts for 0.15% of the portfolio, ranked #90.

XTX Topco first reported a position in ASND in Q3 2021 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

XTX Topco held 43,289 shares of Ascendis Pharma A/S worth $11.5M as of Q2 2026.
XTX Topco bought 31,217 Ascendis Pharma A/S shares in Q2 2026, an estimated $7.29M.
Ascendis Pharma A/S made up 0.15% of XTX Topco's portfolio in Q2 2026, its #90 holding.
XTX Topco first reported a position in Ascendis Pharma A/S in Q3 2021 and has held it in 9 quarters since.
311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.